Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.178,12
-0,18%
NASDAQ
16.276,03
-0,35%
Bitcoin
62.477,04
0,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sensei Biotherapeutics Inc (SNSE) Sensei Biotherapeutics Inc (SNSE) Notizie

Sensei Biotherapeutics Inc

SNSE
1,7878
-0,0222 (-1,23%)
Ultimo aggiornamento: 19:07:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202422:44EDGAR2Form 8-K - Current report
28/2/202413:31EDGAR2Form 8-K - Current report
17/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:31EDGAR2Form 8-K - Current report
04/1/202414:14EDGAR2Form 8-K - Current report
07/11/202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:35EDGAR2Form 8-K - Current report
07/11/202313:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
06/11/202312:07EDGAR2Form 8-K - Current report
03/11/202321:11EDGAR2Form 8-K - Current report
03/11/202321:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
02/11/202321:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202321:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202312:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
25/10/202315:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
23/10/202313:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
20/10/202323:01EDGAR2Form 8-K - Current report
27/9/202313:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
21/9/202313:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
13/9/202314:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202313:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
11/9/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202313:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
17/8/202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:45EDGAR2Form 8-K - Current report
03/8/202313:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
02/8/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202313:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
12/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202322:31EDGAR2Form 8-K - Current report
01/6/202313:30GLOBESensei Biotherapeutics Announces First Patient Dosed in..
09/5/202313:30GLOBESensei Biotherapeutics Reports First Quarter 2023 Financial..
Apertura: 1,80 Min: 1,71 Max: 1,85
Chiusura: 1,81

La tua Cronologia

NASDAQ
SNSE
Sensei Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network